Generic placeholder image

Infectious Disorders - Drug Targets

Author(s): Masoud Keighobadi, Hajar Ziaei Hezarjaribi*, Ali Akbar Khasseh, Masoud Soosaraei, Samira Asadi and Mahdi Fakhar*

DOI: 10.2174/1871526520666200804161110

DownloadDownload PDF Flyer Cite As
Scientometric Analysis of Global Research on Trichomoniasis in Scopus Database (1922 -2018)

Page: [582 - 594] Pages: 13

  • * (Excluding Mailing and Handling)

Explore Articles
About Journal
For Authors
For Editors
For Reviewers

Abstract

Background: Trichomoniasis is a sexually transmitted disease (STD) prevalent in different parts of the world. The present study was designed to evaluate the scientific output and collaboration of researchers worldwide on trichomoniasis.

Methods: In the present scientometric research, all papers conducted on Trichomonas vaginalis (T. vaginalis) published in the time period of 1922 to 2018 were extracted from the Scopus database and evaluated according to the aims of the research, using scientometric software.

Results: The results of this search strategy were the retrieval of 12,596 scientific papers authored by a total of 28,822 people during 97 years (1922-2018). Research in this field has encountered success and failure over the years. The first article on trichomoniasis at the Scopus database was published by Musgrave W.E. (1922) in the “Journal of the American Medical Association”. Most papers on this subject (352) were published in 2013; and the years 2017 and 2016 are ranked second and third. Researchers from the US Centers for Disease Control and Prevention have the highest number of papers in this field (210). Alderete J.F. with 111 papers is the most active researcher on trichomoniasis in Scopus. Also, researchers from the US ranked the first with 3,236 papers. In Iran, by the end of 2018, 138 papers on trichomoniasis have been registered in Scopus, which accounts for only one percent of the world's science production in this field.

Discussion and conclusion: The results following about one century indicated that the number of publications on T. vaginalis is growing and that there is a high level of collaboration among researchers in this field. Moreover, many countries have collaborated internationally on trichomoniasis research with the US as the leading country.

Keywords: Trichomoniasis, T. vaginalis, sexually transmitted disease, bibliometric, scientific collaboration, scopus.

Graphical Abstract

[1]
Kissinger, P. Trichomonas vaginalis: a review of epidemiologic, clinical and treatment issues. BMC Infect. Dis., 2015, 15(1), 307.
[http://dx.doi.org/10.1186/s12879-015-1055-0] [PMID: 26242185]
[2]
World Health Organization (WHO). Sexually transmitted infections: implementing the global STI strategy; WHO, 2017.
[3]
Johnston, V.J.; Mabey, D.C. Global epidemiology and control of Trichomonas vaginalis. Curr. Opin. Infect. Dis., 2008, 21(1), 56-64.
[http://dx.doi.org/10.1097/QCO.0b013e3282f3d999] [PMID: 18192787]
[4]
Meites, E.; Gaydos, C. A.; Hobbs, M. M.; Kissinger, P.; Nyirjesy, P.; Schwebke, J. R. A review of evidence-based care of symptomatic trichomoniasis and asymptomatic Trichomonas vaginalis infections Clinical Infect Dis., 2015, 61(8), s837-S48.
[5]
Sutton, M.; Sternberg, M.; Koumans, E.H.; McQuillan, G.; Berman, S.; Markowitz, L. The prevalence of Trichomonas vaginalis infection among reproductive-age women in the United States, 2001-2004. Clin. Infect. Dis., 2007, 45(10), 1319-1326.
[http://dx.doi.org/10.1086/522532] [PMID: 17968828]
[6]
Rogers, S.M.; Turner, C.F.; Hobbs, M.; Miller, W.C.; Tan, S.; Roman, A.M.; Eggleston, E.; Villarroel, M.A.; Ganapathi, L.; Chromy, J.R.; Erbelding, E. Epidemiology of undiagnosed trichomoniasis in a probability sample of urban young adults. PLoS One, 2014, 9(3), e90548.
[http://dx.doi.org/10.1371/journal.pone.0090548] [PMID: 24626058]
[7]
Van Der Pol, B. Clinical and laboratory testing for Trichomonas vaginalis infection. J. Clin. Microbiol., 2016, 54(1), 7-12.
[http://dx.doi.org/10.1128/JCM.02025-15] [PMID: 26491181]
[8]
Krieger, J.N. Trichomoniasis in men: old issues and new data. Sex. Transm. Dis., 1995, 22(2), 83-96.
[http://dx.doi.org/10.1097/00007435-199503000-00003] [PMID: 7624817]
[9]
Workowski, K. A.; Bolan, G. A. Sexually transmitted diseases treatment guidelines, 2015. MMWR Recommendations and reports : Morbidity and mortality weekly report Recomm Rep 2015, 64(3), 1-137.
[10]
Zhang, Z.F.; Begg, C.B. Is Trichomonas vaginalis a cause of cervical neoplasia? Results from a combined analysis of 24 studies. Int. J. Epidemiol., 1994, 23(4), 682-690.
[http://dx.doi.org/10.1093/ije/23.4.682] [PMID: 8002180]
[11]
Moodley, P.; Wilkinson, D.; Connolly, C.; Moodley, J.; Sturm, A.W. Trichomonas vaginalis is associated with pelvic inflammatory disease in women infected with human immunodeficiency virus. Clin. Infect. Dis., 2002, 34(4), 519-522.
[http://dx.doi.org/10.1086/338399] [PMID: 11797180]
[12]
Cherpes, T.L.; Wiesenfeld, H.C.; Melan, M.A.; Kant, J.A.; Cosentino, L.A.; Meyn, L.A.; Hillier, S.L. The associations between pelvic inflammatory disease, Trichomonas vaginalis infection, and positive herpes simplex virus type 2 serology. Sex. Transm. Dis., 2006, 33(12), 747-752.
[http://dx.doi.org/10.1097/01.olq.0000218869.52753.c7] [PMID: 16691155]
[13]
Silver, B.J.; Guy, R.J.; Kaldor, J.M.; Jamil, M.S.; Rumbold, A.R. Trichomonas vaginalis as a cause of perinatal morbidity: a systematic review and meta-analysis. Sex. Transm. Dis., 2014, 41(6), 369-376.
[http://dx.doi.org/10.1097/OLQ.0000000000000134] [PMID: 24825333]
[14]
Piperaki, E.T.; Theodora, M.; Mendris, M.; Barbitsa, L.; Pitiriga, V.; Antsaklis, A.; Tsakris, A. Prevalence of Trichomonas vaginalis infection in women attending a major gynaecological hospital in Greece: a cross-sectional study. J. Clin. Pathol., 2010, 63(3), 249-253.
[http://dx.doi.org/10.1136/jcp.2009.070920] [PMID: 20203225]
[15]
Aboud, S.; Msamanga, G.; Read, J.S.; Mwatha, A.; Chen, Y.Q.; Potter, D.; Valentine, M.; Sharma, U.; Hoffmann, I.; Taha, T.E.; Goldenberg, R.L.; Fawzi, W.W. Genital tract infections among HIV-infected pregnant women in Malawi, Tanzania and Zambia. Int. J. STD AIDS, 2008, 19(12), 824-832.
[http://dx.doi.org/10.1258/ijsa.2008.008067] [PMID: 19050213]
[16]
Schwebke, J.R.; Burgess, D. Trichomoniasis. Clin. Microbiol. Rev., 2004, 17(4), 794-803.
[http://dx.doi.org/10.1128/CMR.17.4.794-803.2004] [PMID: 15489349]
[17]
Miller, M.; Liao, Y.; Gomez, A.M.; Gaydos, C.A.; D’Mellow, D. Factors associated with the prevalence and incidence of Trichomonas vaginalis infection among African American women in New York city who use drugs. J. Infect. Dis., 2008, 197(4), 503-509.
[http://dx.doi.org/10.1086/526497] [PMID: 18275272]
[18]
Rezaeian, M; Vatanshenassan, M; Rezaie, S; Mohebali, M; Niromand, N; Niyyati, M Prevalence of trichomonas vaginalis using parasitological methods in Tehran. Iran. J. Parasitol., 2009, 4(4), 43-47.
[19]
Hezarjaribi, H.Z.; Fakhar, M.; Shokri, A.; Teshnizi, S.H.; Sadough, A.; Taghavi, M. Trichomonas vaginalis infection among Iranian general population of women: a systematic review and meta-analysis. Parasitol. Res., 2015, 114(4), 1291-1300.
[http://dx.doi.org/10.1007/s00436-015-4393-3] [PMID: 25732256]
[20]
Menéndez, C.; Castellsagué, X.; Renom, M.; Sacarlal, J.; Quintó, L.; Lloveras, B.; Klaustermeier, J.; Kornegay, J.R.; Sigauque, B.; Bosch, F.X.; Alonso, P.L. Prevalence and risk factors of sexually transmitted infections and cervical neoplasia in women from a rural area of southern Mozambique. Infect. Dis. Obstet. Gynecol., 2010, 2010, 44-52.
[http://dx.doi.org/10.1155/2010/609315] [PMID: 20706691]
[21]
Taylor, S.N. Editorial commentary: Trichomonas vaginalis testing and screening in a high-risk population: is this a glimpse into the future?; Oxford University Press, 2014.
[http://dx.doi.org/10.1093/cid/ciu448]
[22]
Dunne, R.L.; Dunn, L.A.; Upcroft, P.; O’Donoghue, P.J.; Upcroft, J.A. Drug resistance in the sexually transmitted protozoan Trichomonas vaginalis. Cell Res., 2003, 13(4), 239-249.
[http://dx.doi.org/10.1038/sj.cr.7290169] [PMID: 12974614]
[23]
Bachmann, L.H.; Hobbs, M.M.; Seña, A.C.; Sobel, J.D.; Schwebke, J.R.; Krieger, J.N.; McClelland, R.S.; Workowski, K.A. Trichomonas vaginalis genital infections: progress and challenges. Clin. Infect. Dis., 2011, 53(Suppl. 3), S160-S172.
[http://dx.doi.org/10.1093/cid/cir705] [PMID: 22080269]
[24]
Rodriguez, A.E. Scientific production by cardiologists and scientific societies of cardiology: differences and similarities between argentina and regional and central countries Rev Arg Cardiol, 2012, 80, 52-57.
[25]
Chinchilla‐Rodríguez, Z.; Benavent‐Pérez, M.; de Moya‐Anegón, F.; Miguel, S. International collaboration in Medical Research in Latin America and the Caribbean (2003–2007). J. Am. Soc. Inf. Sci. Technol., 2012, 63(11), 2223-2238.
[26]
Current Concepts in Bacterial Sexually Transmitted Diseases. Korean J. Urol., 2011, 52(9), 589-597.
[http://dx.doi.org/10.4111/kju.2011.52.9.589] [PMID: 22025952]
[27]
Calvet, H.M.; Calvet, H.M. Sexually transmitted diseases other than human immunodeficiency virus infection in older adults. Clin. Infect. Dis., 2003, 36(5), 609-614.
[http://dx.doi.org/10.1086/367892] [PMID: 12594642]
[28]
Jones, R.E.; Lopez, K.H. Human reproductive biology; Academic Press, 2013.
[29]
World Health Organization(WHO). Strategies and laboratory methods for strengthening surveillance of sexually transmitted infections., 2011. Available from : http://www.who.int/reproductivehealth/publications/rtis/9789241504478/en/
[30]
Brookmeyer, K. A.; Hogben, M.; Kinsey, J. The Role of Behavioral Counseling in STD Prevention Program Settings Sex Transm Dis., 2016, 43(001), S102.
[31]
Uzun, A. A scientometric profile of social sciences research in Turkey. Int. Inf. Libr. Rev., 1998, 30(3), 169-184.
[http://dx.doi.org/10.1080/10572317.1998.10762473]
[32]
Tian, Y.; Wen, C.; Hong, S. Global scientific production on GIS research by bibliometric analysis from 1997 to 2006. J. Informetrics, 2008, 2(1), 65-74.
[http://dx.doi.org/10.1016/j.joi.2007.10.001]
[33]
Bharvi, D.; Garg, K.; Bali, A. Scientometrics of the international journal Scientometrics. Scientometr, 2003, 56(1), 81-93.
[http://dx.doi.org/10.1023/A:1021950607895]
[34]
Molina, N.B. The scholarly communication in the science 2.0 era; J Med Microb Diagn, 2012, p. e108.
[35]
Bordons, M.; Zulueta, M.A. Evaluación de la actividad científica a través de indicadores bibliométricos. Rev. Esp. Cardiol., 1999, 52(10), 790-800.
[http://dx.doi.org/10.1016/S0300-8932(99)75008-6] [PMID: 10563155]
[36]
Sancho, R. Indicadores bibliométricos utilizados en la evaluación de la ciencia y la tecnología. Revisión bibliográfica. Rev. Esp. Doc. Cient., 1990, 13(3), 842.
[37]
Sanz-Valero, J.; Casterá, V.T.; Wanden-Berghe, C. Estudio bibliométrico de la producción científica publicada por la Revista Panamericana de Salud Pública/ Pan American Journal of Public Health en el período de 1997 a 2012. Rev. Panam. Salud Publica, 2014, 35(2), 81-88.
[PMID: 24781088]
[38]
Martínez, A.M.; Fink, N.E. Análisis bibliométrico de las comunicaciones presentadas en el Congreso Nacional Bioquímico entre 1997 y 2005. Acta Bioquim. Clin. Latinoam., 2008, 42(2), 261-269.
[39]
Zacca-González, G.; Chinchilla-Rodríguez, Z.; Vargas-Quesada, B.; de Moya-Anegón, F. Bibliometric analysis of regional Latin America’s scientific output in public health through SCImago journal & country rank. BMC Public Health, 2014, 14(1), 632.
[http://dx.doi.org/10.1186/1471-2458-14-632] [PMID: 24950735]